Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
61,919,993
-
Shares change
-
+3,538,172
-
Total reported value, excl. options
-
$2,094,320,996
-
Value change
-
+$114,605,453
-
Put/Call ratio
-
71.6%
-
Number of buys
-
102
-
Number of sells
-
-81
-
Price
-
$33.82
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2019
230 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2019.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61,919,993 shares
of 80,437,135 outstanding shares and own 77% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (5,428,649 shares), VANGUARD GROUP INC (5,169,992 shares), BlackRock Inc. (4,706,096 shares), PRICE T ROWE ASSOCIATES INC /MD/ (3,749,518 shares), RTW INVESTMENTS, LP (3,651,361 shares), FMR LLC (2,452,582 shares), Point72 Asset Management, L.P. (2,388,607 shares), CITADEL ADVISORS LLC (2,171,616 shares), STATE STREET CORP (2,074,902 shares), and GREAT POINT PARTNERS LLC (2,000,000 shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.